UROPLASTY INC
10QSB, EX-27, 2000-11-09
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: UROPLASTY INC, 10QSB, 2000-11-09
Next: PRIME RECEIVABLES CORP, S-3/A, 2000-11-09



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   4-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       1,501,002
<SECURITIES>                                         0
<RECEIVABLES>                                  810,449
<ALLOWANCES>                                         0
<INVENTORY>                                    980,969
<CURRENT-ASSETS>                             3,596,557
<PP&E>                                       1,562,120
<DEPRECIATION>                               (590,812)
<TOTAL-ASSETS>                               4,681,492
<CURRENT-LIABILITIES>                          807,520
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        59,853
<OTHER-SE>                                   3,348,607
<TOTAL-LIABILITY-AND-EQUITY>                 4,681,492
<SALES>                                      1,211,267
<TOTAL-REVENUES>                             1,211,267
<CGS>                                          218,692
<TOTAL-COSTS>                                  218,692
<OTHER-EXPENSES>                             1,382,539
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,429
<INCOME-PRETAX>                              (783,810)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (783,810)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (783,810)
<EPS-BASIC>                                      (.13)
<EPS-DILUTED>                                    (.13)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission